SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-271664
Filing Date
2022-10-28
Accepted
2022-10-28 06:05:57
Documents
15
Period of Report
2022-10-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d377694d8k.htm   iXBRL 8-K 39500
2 EX-99.1 d377694dex991.htm EX-99.1 33858
6 GRAPHIC g377694g1027102858261.jpg GRAPHIC 3397
7 GRAPHIC g377694g14p38.jpg GRAPHIC 12604
  Complete submission text file 0001193125-22-271664.txt   234669

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20221028.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20221028_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20221028_pre.xml EX-101.PRE 11711
9 EXTRACTED XBRL INSTANCE DOCUMENT d377694d8k_htm.xml XML 3526
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 221338884
SIC: 2834 Pharmaceutical Preparations